Direct generation of complex genetically-modified mouse models via embryonic stem cells
通过胚胎干细胞直接生成复杂的转基因小鼠模型
基本信息
- 批准号:10589018
- 负责人:
- 金额:$ 21.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-15 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAllelesAnimal ModelAnimalsBiological ModelsBiologyBreedingBypassCRISPR/Cas technologyCattleCell Culture SystemCell Culture TechniquesChimera organismComplementComplexConsumptionDataDevelopmentDifferentiation InhibitorES Cell LineEmbryoEpigenetic ProcessExploratory/Developmental Grant for Diagnostic Cancer ImagingFemaleFosteringGenerationsGenesGeneticGenetically Modified AnimalsGenomeGenomic InstabilityGoalsKnock-inKnockout MiceLipidsMAPK3 geneMEK inhibitionMEKsMaintenanceMediatingMedical ResearchMeditationModificationMouse StrainsMusMutationPathway interactionsProcessProductionPublic HealthResearchResearch PersonnelSerumSerum-Free Culture MediaSignal PathwaySiteSpeedStem cell pluripotencySystemTechnologyTestingTimeUnited States National Institutes of HealthY chromosome deletionconditional knockoutcostembryonic stem cellflexibilitygenetic manipulationhigh rewardhigh riskhuman diseaseimprovedinducible Creinhibitorinterestmalemouse modelmutantnovelpluripotencypreservationsexstem cellstooltransmission process
项目摘要
PROJECT SUMMARY: Genetically modified (GM) animals are essential tools for the
study of both fundamental biology and human diseases. The production of GM animals
relies on two critical technologies: 1) stable genetic modifications and 2) germline
transmission of the mutations into a model system. A typical approach for creation of
complex GM mice involves the generation of tetra-parental chimeras from normal
embryos and GM embryonic stem (ES) cells, followed by multiple rounds of breeding to
obtain both male and female mice for germline propagation. Two limitations dominate
this approach. First, maintenance of pluripotency limits the complexity of genetic
manipulations. Second, this process is time-consuming, laborious, and costly,
particularly if the final objective requires many independent germline manipulations in
the same animal. We propose a feasible strategy to accelerate the production of
complex GM mouse models. Employing the technology of sex-reversion via
CRISPR/Cas9-meditated Y chromosome deletion in male ES cells and our novel ES
cell culture system, we can directly generate isogenic male and female mice from the
same targeted ES cells through tetraploid complementation (4n). This strategy would
bypass at least two mouse breeding generations: the chimera development step and
the complex breeding process. We will target male (XY) ES cell lines for intended
genetic alterations and follow the deletion of Y chromosome to generate monosomic XO
female ES cells. Using this strategy, compound homozygous GM mouse strains could
be established at unparalleled speed and costs. In this R21 application we propose the
following two Aims: Aim 1: Optimize AX-based ES cell culture system for the production
of GM mouse models. Aim 2. Direct generation of isogenic male and female complex
GM mice using novel ES cell culture medium. If successful, our approach would have a
great impact on GM mouse model construction in terms of versatility, speed, and cost.
This ambitious endeavor to develop a breakthrough technology for creation of complex
GM mouse models would also possibly foster novel research opportunities.
项目概述:转基因(GM)动物是人类发展的重要工具。
基础生物学和人类疾病的研究。转基因动物的生产
依赖于两项关键技术:1)稳定的遗传修饰和2)种系
将突变传递到模型系统中。一种典型的创建
复杂的转基因小鼠涉及从正常的四亲嵌合体的产生,
胚胎和转基因胚胎干细胞(ES细胞),然后进行多轮育种,
获得雄性和雌性小鼠用于生殖系繁殖。两个限制占主导地位
这种方法。首先,多能性的维持限制了遗传学的复杂性。
操纵第二,这个过程是费时、费力和昂贵的,
特别是如果最终目的需要许多独立的种系操作,
同样的动物。我们提出了一个可行的战略,以加快生产,
复杂的转基因小鼠模型。采用性逆转技术,
CRISPR/Cas9介导的男性ES细胞中的Y染色体缺失和我们的新ES
细胞培养系统,我们可以直接从雄性小鼠和雌性小鼠产生同基因的
通过四倍体互补(4 n)相同的靶向ES细胞。这一战略将
绕过至少两代小鼠繁殖:嵌合体发育步骤,
复杂的繁殖过程。我们将靶向男性(XY)ES细胞系,
遗传改变并随后缺失Y染色体以产生单体XO
女性ES细胞使用这种策略,复合纯合GM小鼠品系可以
以无与伦比的速度和成本建立。在此R21应用中,我们提出
目的1:优化AX-ES细胞培养体系,
转基因小鼠模型。目标2.同基因雌雄复合体的直接产生
使用新型ES细胞培养基的GM小鼠。如果成功,我们的方法将有一个
在通用性、速度和成本方面对GM小鼠模型构建有很大影响。
这一雄心勃勃的奋进,以开发一种突破性的技术,创造复杂的
转基因小鼠模型也可能促进新的研究机会。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Duancheng Wen其他文献
Duancheng Wen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Duancheng Wen', 18)}}的其他基金
Direct generation of complex genetically-modified mouse models via embryonic stem cells
通过胚胎干细胞直接生成复杂的转基因小鼠模型
- 批准号:
10354630 - 财政年份:2022
- 资助金额:
$ 21.19万 - 项目类别:
H3.3-mediated epigenetic regulation of developmental bivalent genes for reprogramming and differentiation
H3.3介导的发育二价基因的表观遗传调控,用于重编程和分化
- 批准号:
10408113 - 财政年份:2018
- 资助金额:
$ 21.19万 - 项目类别:
H3.3-mediated epigenetic regulation of developmental bivalent genes for reprogramming and differentiation
H3.3介导的发育二价基因的表观遗传调控,用于重编程和分化
- 批准号:
9750724 - 财政年份:2018
- 资助金额:
$ 21.19万 - 项目类别:
H3.3-mediated epigenetic regulation of developmental bivalent genes for reprogramming and differentiation
H3.3介导的发育二价基因的表观遗传调控,用于重编程和分化
- 批准号:
10174958 - 财政年份:2018
- 资助金额:
$ 21.19万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 21.19万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 21.19万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 21.19万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 21.19万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 21.19万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 21.19万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 21.19万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 21.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 21.19万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 21.19万 - 项目类别: